According to KOBAYASHI Pharmaceutical's latest financial reports the company has HK$3.25 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | HK$4.42 B | -29.13% |
2022-12-31 | HK$6.24 B | -15.53% |
2021-12-31 | HK$7.38 B | 4.2% |
2020-12-31 | HK$7.09 B | 9.48% |
2019-12-31 | HK$6.47 B | 10.28% |
2018-12-31 | HK$5.87 B | 15.57% |
2017-12-31 | HK$5.08 B | |
2016-03-31 | HK$4.54 B | 11.85% |
2015-03-31 | HK$4.06 B | -2.71% |
2014-03-31 | HK$4.18 B | 7.18% |
2013-03-31 | HK$3.90 B | -22.67% |
2012-03-31 | HK$5.04 B | 25.41% |
2011-03-31 | HK$4.02 B | 13.53% |
2010-03-31 | HK$3.54 B | 57.06% |
2009-03-31 | HK$2.25 B | 26.05% |
2008-03-31 | HK$1.78 B | 23.25% |
2007-03-31 | HK$1.45 B | -15.04% |
2006-03-31 | HK$1.70 B | 17.19% |
2005-03-31 | HK$1.45 B |